» Articles » PMID: 37799370

Psychiatric Comorbidities on an Inpatient Dermatology Consultation Service: A Cross-sectional Analysis

Overview
Journal Skin Health Dis
Specialty Dermatology
Date 2023 Oct 6
PMID 37799370
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the high prevalence of psychiatric illness in hospitalised dermatology patients, characterisation of psychiatric comorbidities on an inpatient dermatology consultation service in the United States has yet to be performed. To fill this gap in knowledge, we investigated the prevalence of and factors associated with psychiatric illness on the inpatient dermatology consultation service at the University of Southern California. Of the 429 patients seen by the dermatology consultation service between June 2021 to July 2022, 147 (34%) had psychiatric illness (defined as having at least 1 psychiatric diagnosis). Increasing age was associated with a decreased likelihood of psychiatric illness, while housing instability, chronic dermatologic disease, drug reaction, and pruritus without rash were associated with an increased likelihood of psychiatric illness. The high prevalence of psychiatric illness observed in hospitalised dermatology patients emphasises the importance of collaboration between consultant dermatologists and mental health specialists, particularly when specific sociodemographic or disease factors are present.

References
1.
Cook J, Burke-Miller J, Razzano L, Steigman P, Jonikas J, Santos A . Serious mental illness, other mental health disorders, and outpatient health care as predictors of 30-day readmissions following medical hospitalization. Gen Hosp Psychiatry. 2021; 70:10-17. DOI: 10.1016/j.genhosppsych.2021.02.004. View

2.
Charlson M, Carrozzino D, Guidi J, Patierno C . Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom. 2022; 91(1):8-35. DOI: 10.1159/000521288. View

3.
Chiang C, Hung C, Chen Y, Chen C, Soong C, Liu S . Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan. J Dermatol. 2022; 49(10):979-987. DOI: 10.1111/1346-8138.16487. View

4.
Walker E, McGee R, Druss B . Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015; 72(4):334-41. PMC: 4461039. DOI: 10.1001/jamapsychiatry.2014.2502. View

5.
Hsu D, Smith B, Silverberg J . Atopic Dermatitis and Hospitalization for Mental Health Disorders in the United States. Dermatitis. 2018; 30(1):54-61. PMC: 6450561. DOI: 10.1097/DER.0000000000000418. View